1. Home
  2. SAGE vs YORW Comparison

SAGE vs YORW Comparison

Compare SAGE & YORW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAGE
  • YORW
  • Stock Information
  • Founded
  • SAGE 2010
  • YORW 1816
  • Country
  • SAGE United States
  • YORW United States
  • Employees
  • SAGE N/A
  • YORW N/A
  • Industry
  • SAGE Biotechnology: Pharmaceutical Preparations
  • YORW Water Supply
  • Sector
  • SAGE Health Care
  • YORW Utilities
  • Exchange
  • SAGE Nasdaq
  • YORW Nasdaq
  • Market Cap
  • SAGE 474.6M
  • YORW 475.9M
  • IPO Year
  • SAGE 2014
  • YORW N/A
  • Fundamental
  • Price
  • SAGE $7.37
  • YORW $35.41
  • Analyst Decision
  • SAGE Hold
  • YORW
  • Analyst Count
  • SAGE 19
  • YORW 0
  • Target Price
  • SAGE $9.88
  • YORW N/A
  • AVG Volume (30 Days)
  • SAGE 1.2M
  • YORW 71.0K
  • Earning Date
  • SAGE 04-24-2025
  • YORW 05-06-2025
  • Dividend Yield
  • SAGE N/A
  • YORW 2.48%
  • EPS Growth
  • SAGE N/A
  • YORW N/A
  • EPS
  • SAGE N/A
  • YORW 1.42
  • Revenue
  • SAGE $41,243,000.00
  • YORW $74,959,000.00
  • Revenue This Year
  • SAGE $100.39
  • YORW $7.50
  • Revenue Next Year
  • SAGE $70.86
  • YORW $6.33
  • P/E Ratio
  • SAGE N/A
  • YORW $24.91
  • Revenue Growth
  • SAGE N/A
  • YORW 5.53
  • 52 Week Low
  • SAGE $4.62
  • YORW $29.86
  • 52 Week High
  • SAGE $17.51
  • YORW $41.96
  • Technical
  • Relative Strength Index (RSI)
  • SAGE 40.58
  • YORW 63.58
  • Support Level
  • SAGE $7.99
  • YORW $34.21
  • Resistance Level
  • SAGE $7.97
  • YORW $35.31
  • Average True Range (ATR)
  • SAGE 0.31
  • YORW 0.72
  • MACD
  • SAGE -0.10
  • YORW 0.06
  • Stochastic Oscillator
  • SAGE 1.37
  • YORW 95.89

About SAGE Sage Therapeutics Inc.

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.

About YORW York Water Company (The)

The York Water Co is an investor-owned water utility company in the United States. The primary business of the company is to impound, purify to meet or exceed safe drinking water standards and distribute water. It also owns and operates three wastewater collection systems and two wastewater treatment systems. The company operates within its franchised territory, which covers more than 54 municipalities within York County, Pennsylvania.

Share on Social Networks: